Michael P Stansky
Director at TriSalus Life Sciences, Inc. (TLSI)
Purchase track record
Above average. Based on 2 purchases with a full 90 days of price history.
68
Avg. 90-day return+19.2%
vs. S&P 500+11.6%
Beat the market50%
Paper profit on buys+$937K
Total bought / sold$3.0M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 18SEC | TLSITriSalus Life Sciences, Inc. | Buy | 410,0001,240,722 held (+49%) | $2.50 | $1.0M | +62.4% |
| May 18SEC | TLSITriSalus Life Sciences, Inc. | Buy | 200,000399,698 held (+100%) | $2.50 | $500K | +62.4% |
| Feb 23SEC | TLSITriSalus Life Sciences, Inc. | Buy | 243,900787,132 held (+45%) | $4.10 | $1000K | -1.0% |
| Feb 23SEC | TLSITriSalus Life Sciences, Inc. | Buy | 117,198199,698 held (+142%) | $4.10 | $481K | -1.0% |
- Buy
Director Michael P Stansky bought $1.0M of TLSI at $2.50 — raises the stake by 49%.
- Buy
Director Michael P Stansky bought $500K of TLSI at $2.50 — raises the stake by 100%.
- Buy
Director Michael P Stansky bought $1000K of TLSI at $4.10 — first open-market purchase in our records; raises the stake by 45%.
- Buy
Director Michael P Stansky bought $481K of TLSI at $4.10 — raises the stake by 142%.